Numerical and Experimental Studies of an Oil Slick Recovery Method That Uses a Free Surface Vortex

por Yang, Meng, Liu, Shuo, Xu, Wan-hai, Xu, Jing-yu
Publicado 2020

Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma

por Qiao, Zhen-kui, Li, Yan-long, Lu, Hong-tao, Wang, Ke-liang, Xu, Wan-hai
Publicado 2013

Unusual presentation of urachal adenocarcinoma with genitourinary cutaneous metastasis

por Yang, Yin-Hui, Zhu, Yan, Zhu, Xiang-Wei, Tang, Hong-Juan, Hou, Jian-Guo, Xu, Wan-Hai
Publicado 2015

Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer

por Liu, Yang, Wang, Chang-Lin, Pang, Zhong-Qi, Gao, Ke, Shen, Lin-Kun, Xu, Wan-Hai, Ren, Ming-Hua
Publicado 2023

A bioactivated in vivo assembly nanotechnology fabricated NIR probe for small pancreatic tumor intraoperative imaging

por Ren, Han, Zeng, Xiang-Zhong, Zhao, Xiao-Xiao, Hou, Da-yong, Yao, Haodong, Yaseen, Muhammad, Zhao, Lina, Xu, Wan-hai, Wang, Hao, Li, Li-Li
Publicado 2022

Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity

por Wang, Gang, Zhang, Da-Ming, Zhuang, Hai-Ying, Yin, Chao, Liu, Jing, Wang, Zi-Chun, Cai, Li-Cheng, Ren, Ming-Hua, Xu, Wan-Hai, Zhang, Cheng
Publicado 2017

The correlation of ESCO1 expression with a prognosis of prostate cancer and anti-tumor effect of ESCO1 silencing

por Wang, Hui, Lv, Yan-Ju, Xu, Wan-Hai, Pang, Wei-Feng, Zhao, Yu-Ying, Yang, Ning, Wang, Zhi-Peng, Lu, Lu, Liu, Ying, Zhang, Shi-Ying, Yuan, Xue-Li
Publicado 2019

miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling

por Wang, Zhi-Chao, Li, Yan, Wang, Ke-Liang, Wang, Lu, You, Bo-Sen, Zhao, Dan-Feng, Liu, Zhong-Qing, Fang, Rui-Zhe, Wang, Jia-Qi, Zhang, Wei, Zhang, Jin-Ming, Xu, Wan-Hai
Publicado 2020

Retraction: miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling

por Wang, Zhi-Chao, Li, Yan, Wang, Ke-Liang, Wang, Lu, You, Bo-Sen, Zhao, Dan-Feng, Liu, Zhong- Qing, Fang, Rui-Zhe, Wang, Jia-Qi, Zhang, Wei, Zhang, Jin-Ming, Xu, Wan-Hai
Publicado 2020

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition)

por Zeng, Xian-Tao, Jin, Ying-Hui, Liu, Tong-Zu, Chen, Fang-Ming, Ding, De-Gang, Fu, Meng, Gu, Xin-Quan, Han, Bang-Min, Huang, Xing, Hou, Zhi, Hu, Wan-Li, Kang, Xin-Li, Li, Gong-Hui, Li, Jian-Xing, Li, Pei-Jun, Liang, Chao-Zhao, Liu, Xiu-Heng, Liu, Zhi-Yu, Liu, Chun-Xiao, Liu, Jiu-Min, Luo, Guang-Heng, Luo, Yi, Qin, Wei-Jun, Qiu, Jian-Hong, Qiu, Jian-Xin, Shang, Xue-Jun, Shi, Ben-Kang, Sun, Fa, Tian, Guo-Xiang, Tian, Ye, Wang, Feng, Wang, Feng, Wang, Yin-Huai, Wang, Yu-Jie, Wang, Zhi-Ping, Wang, Zhong, Wei, Qiang, Xiao, Min-Hui, Xu, Wan-Hai, Yi, Fa-Xian, Zhu, Chao-Yang, Zhuang, Qian-Yuan, Zhou, Li-Qun, Zou, Xiao-Feng, Xing, Nian-Zeng, He, Da-Lin, Wang, Xing-Huan
Publicado 2022